A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State.

Item

http://www.wikidata.org/entity/Q35953512

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State.

@ast

A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State.

@en

type

Item

label

A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State.

@ast

A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State.

@en

prefLabel

A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State.

@ast

A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State.

@en

P1476

A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State.

@en

P2093

David S Small

http://www.w3.org/2001/XMLSchema#string

Delyn Downs

http://www.w3.org/2001/XMLSchema#string

Ellen A Cannady

http://www.w3.org/2001/XMLSchema#string

Jane Royalty

http://www.w3.org/2001/XMLSchema#string

Jeffrey G Suico

http://www.w3.org/2001/XMLSchema#string

Stuart Friedrich

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk.

Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.

Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults

Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

The pharmacokinetics and pharmacokinetic/pharmacodynamic relationships of evacetrapib administered as monotherapy or in combination with statins.

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects.

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial.

P304

483-489

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1074248415575153

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273151809

http://www.w3.org/2001/XMLSchema#string

P698

25736283

http://www.w3.org/2001/XMLSchema#string

P932

4536537

http://www.w3.org/2001/XMLSchema#string